Herbal treatment of Parkinsonism: A review

International Journal of Pharmaceutical Sciences Review and Research

Volumn 5, Issue 3, 2010, Pages 185-191

  Kartika, Borra ^a   Muralidharan, Palayyan ^a   Rahman, Habibur ^a  

^a C L BAID METHA COLLEGE OF PHARMACY   (India)

Author keywords

Antiapoptotic; Antioxidant; Herbal treatment; Neuroprotective; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMANTADINE; ANEMOPAEGMA MIRANDU EXTRACT; ANTIPARKINSON AGENT; BACOPA MONNIERI EXTRACT; BENSERAZIDE; BROMOCRIPTINE; CARBIDOPA; CASSIAE SEMEN EXTRACT; CENTELLA ASIATICA EXTRACT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHRYSANTHEMUM MORIFOLIUM EXTRACT; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; GASTRODIA ELATA EXTRACT; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; LEVODOPA; MUCUNA PRURIENS EXTRACT; NARDOSTACHYS JATAMANSI EXTRACT; OXIDOPAMINE; PLANT EXTRACT; PLUMBAGO SCANDENS EXTRACT; PUERARIA THOMSONII EXTRACT; ROTENONE; SELEGILINE; THUJA ORIENTALIS EXTRACT; UNCARIA RHYNCHOPHYLLA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; WITHANIA SOMNIFERA EXTRACT;

ANEMOPAEGMA MIRANDU; ANTIOXIDANT ACTIVITY; APOPTOSIS; AYURVEDA; BIGNONIACEAE; CASSIAE SEMEN; CATECHOLAMINE NERVE CELL; CHINESE MEDICINE; CHRYSANTHEMUM; CHRYSANTHEMUM MORIFOLIUM; CLINICAL FEATURE; DOSE RESPONSE; DRUG DEGRADATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENTIATION; DYSKINESIA; ENCEPHALITIS; ENZYME INHIBITION; GENETIC SUSCEPTIBILITY; HERBAL MEDICINE; HUMAN; LOW DRUG DOSE; MITOCHONDRIAL DNA DISORDER; MOTOR DYSFUNCTION; NARDOSTACHYS; NARDOSTACHYS JATAMANSII; NERVE CELL NECROSIS; NEUROIMAGING; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PARKINSONISM; PLUMBAGINACEAE; PLUMBAGO SCANDENS; PUERARIA; PUERARIA THOMSONII; REVIEW; SENNA; THUJA; THUJA ORIENTALIS; UNCARIA; UNCARIA RHYNCHOPHYLLA;

EID: 79952064259     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Speciale SG. MPTP: insights into parkinsonian neurodegeneration. Neurotoxicol Teratol, 24, 2002, 607-20.
2. Abbas N, Lucking CB, Ricard S, Durr A, Brice A. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's disease genetics study group and the European consortium on genetic susceptibility in Parkinson's disease. Human Molecular Genetics, 8(4), 1999, 567-74.
3. Oliveri RL, Zappia M, Annesi G, Bosco D, Quattrone A. The parkin gene is not involved in late-onset Parkinson's disease. Neurology, 57(2), 2001, 359-62.
4. Rajput AH. Frequency and cause of Parkinson's disease.Can J Neurol Sci, 19 (1 suppl), 1992, 103-07.
5. De Rijk MC, Launer LJ, Berger K, et al. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurology, 54 (11 suppl 5), 2000, S21-23.
6. Baldereschi M, Di Carlo A, Rocca WA, et al. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. Neurology, 55, 2000, 1358-63.
7. Lai BC, Schulzer M, Marion S, Teschke K, Tsui JK. The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology. Parkinsonism Relat Disord 9, 2003, 233-38
8. Lees AJ (September 2007) "Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday". Movement disorder, 22 Suppl 17, S327-S334.
9. Mosley R.L., Benner, E.J., Kadiu, I., Thomas, M., Boska, M.D., Hasan, K., Laurie, C., Gendelman, H.E., 2006. Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease. Clin. Neurosci. Res., 6, 261-281.
10. Sherer T.B., Betarbet, R., Greenamyre, J.T., 2002. Environment, mitochondria, and Parkinson's disease. The Neuroscientist, 8, 192-197.
11. Fearnley JM, Lees A. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain, 114, 1991, 2283-301
12. Lopez-Real, A., Rey, P., Soto-Otero, R., Mendez- Alvarez, E., Labandeira-Garcia, J.L., 2005. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism. Journal Neuroscience Research 81, 865-873.
13. Przedborski S., Jackson-Lewis, V., Mechanisms of MPTP toxicity Movement Disorders 13, 1998, 35-38.
14. viartis.net/parkinsons.disease/toxic.causes.htm
15. www.emedicinehealth.com.
16. Luo Y., Hattori, A., Munoz, J., Qin, Z.H., Roth, G.S., 1999. Intrastriatal dopamine injection induces apoptosis through oxidative-involved activation of transcription factors AP-1 and NF-nh in rats. Mol. Pharmacol. 56, 254-264.
17. McGeer PL, McGeer EG, Suzuki JS. Aging and extrapyramidal function. Arch Neurol., 34, 1998, 33-35.
18. http://www.holisticonline.com/remedies/parkinson/pd_causes.htm
19. Stoessl AJ, Rivest J. Differential diagnosis of parkinsonism. Can J Neurol Sci., 26(suppl 2), 1999, S1-4. SEMINAR
20. Parkinson J (2002). "An essay on the shaking palsy. 1817". The Journal of Neuropsychiatry and Clinical Neurosciences 14 (2): 223-36;discussion 222.
21. Wijker M, Wszolek ZK, Wolters EC, et al. Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallidoponto- nigral degeneration to chromosome 17q21. Hum Mol Genet 1996;5: 151-54.
22. Demirkiran M, Bozdemir H, Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand, 104, 2001, 63-67.
23. Lee CS, Samii A, Sossi V, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol, 47, 2000, 493-503.
24. Winogrodzka A, Bergmans P, Booij J, van Royen EA, Janssen AG, Wolters EC. [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease. J Neural Transm, 108, 2001, 1011-19.
25. H.P Rang, M.M dale, J.M.Ritter and R.J. Flower, Rang and Dale's Pharmacology, ^th edition, pg no. 517-521.
26. Finkel, Richard; Clark, Michelle A.; Cubeddu, Luigi X, Lippincott's Illustrated Reviews: Pharmacology, 4th Edition, Pg no. 156-163.
27. Takahiko Fujikawaa, Shinji Miguchia, Nariyasu Kanadaa, Naoya Nakaia, Masato Ogataa, Ikukatsu Suzukib, Kunio Nakashimac Acanthopanax senticosus Harms as a prophylactic for MPTPinduced Parkinson's disease in rats, Journal of Ethnopharmacology 97, 2005, 375-381.
28. Srinivasagam RajaSankara, Thamilarasan Manivasagam, Venkatachalam Sankar, Seppan Prakash, Rathinasamy Muthusamyd, Arumugam Krishnamurti, Sankar Surendran, Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse, Journal of Ethnopharmacology 125, 2009, 369-373.
29. Jin Sup Shima, Hyo Geun Kima, Mi Sun Jua, Jin Gyu Choia, Seo Young Jeongb, C., Myung Sook Oha, Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease, Journal of Ethnopharmacology 126, 2009, 361-365
30. Muzamil Ahmad, Seema Yousuf, M. Badruzzaman Khan, Md. Nasrul Hoda, Abdullah Shafique Ahmad, Mubeen Ahmad Ansari, Tauheed Ishrat, Ashok Kumar Agrawal, Fakhrul Islam, Attenuation by Nardostachys jatamansi of 6-hydroxydopamineinduced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies, Pharmacology, Biochemistry and Behavior 83, 2006, 150-160
31. Su Kima, Sushruta Koppulaa, Pyo-Jam Parka, Ee Hwa Kimb, Chan Gil Kima, Wahn Soo Choic, Kwang Ho Leea, Dong-Kug Choia Chrysanthemum morifolium Ramat (CM) extract protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity, Journal of Ethnopharmacology 126, 2009, 447-454.
32. Mi Sun Ju, Hyo Geun Kim, Jin Gyu Choi, Jong Hoon Ryu, Jinyoung Hur, Youn Jung Kim, Myung Sook Oha, Cassiae semen, a seed of Cassia obtusifolia, has neuroprotective effects in Parkinson's disease models, Food and Chemical Toxicology 48, 2010, 2037-2044.
33. Deyse Valverde G. De Andradea, Diêgo Madureira de Oliveriaa, George Barretoa, Laura-Aon Bertolinob, Ezequiel Saracenob, Francisco Capanib, Lisandro Diego Giraldeza, Effects of the extract of Anemopaegma mirandum (Catuaba) on Rotenoneinduced apoptosis in human neuroblastomas SHSY5Y cells, Brain Research 1198, 2008, 188-196
34. M.I. Sánchez-Reus, M.A. Go ́mez del Rio, I. Iglesias, M. Elorza, K. Slowing, J. Benedi{dotless}, Standardized Hypericum perforatum reduces oxidative stress and increases gene expression of antioxidant enzymes on rotenone-exposed rats, Neuropharmacology 52, 2007, 606-616.
35. M. Mohanasundari, M.S. Srinivasan, S. Sethupathy, M. Sabesan, Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice, Journal of the Neurological Sciences 249, 2006, 140-144.
36. Hua Ana, In Su Kima, Sushruta Koppulaa, Byung Wook Kima, Pyo Jam Parka, Beong Ou Limb, Wahn Soo Choic, Kwang Ho Leea, Dong Kug Choia, Protective effects of Gastrodia elata Blume on MPP+-induced cytotoxicity in human dopaminergic SH-SY5Y cells, Journal of Ethnopharmacology 130, 2010, 290-298.
37. Nagaraja Haleagrahara and Kumar Ponnusamy, Neuroprotective effect of Centella asiatica extract (CAE) on experimentally induced parkinsonism in aged Sprague-Dawlwy rats, J.toxicol.Sci vol. 35, 2010, 41-47.
38. Mi Sun Ju, Pyeongjae Lee, Hyo Geun Kim, Ki Yong Lee, Jinyoung Hur, Seung-Hun Cho, Sang Hyun Sung, Myung Sook Oha, Protective effects of standardized Thuja orientalis leaves against6- hydroxydopamine-induced neurotoxicity in SH-SY5Y cells, Toxicology in Vitro 24, 2010, 759-765.
39. A. Pinna, S. Pontis, N. Schintu, N. Simola, S. Kasture, M. Morelli. Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease, Poster presentations / Parkinsonism and Related Disorders 15S2, 2009, S29-S199.
40. Muzamil Ahmad, Sofiyan Saleem, Abdullah Shafique Ahmad, Seema Yousuf, Mubeen Ahmad Ansari, M Badruzzaman, Ginkgo biloba affords dosedependent protection against 6-hydroxydopamineinduced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences, Journal of Neurochemistry, 93, 2005, 94-104.
41. L.C.S.L. Morais, L.J. Quintans-Ju ́ nior, C.I.F. Franco, J.R.G.S. Almeida, R.N. Almeida Antiparkinsonian-like effects of Plumbago scandens on tremorine-induced tremors methodology Pharmacology, Biochemistry and Behavior 79, 2004, 745-749.
42. Amar Jyoti, Deepak Sharma. Neuroprotective role of Bacopa monniera extract against aluminiuminduced oxidative stress in the hippocampus of rat brain, NeuroToxicology 27, 2006, 451-457.
43. Ravikumar Hosamani, Muralidhara. Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster, NeuroToxicology 30, 2009, 977-985.
44. Chien-Min Lin, Rong-Dih Lin, Shui-Tein Chen, Yi-Pei Lin, Wen-Ta Chiu, Jia-Wei Lin, Feng-Lin Hsu, Mei- Hsien Lee. Neurocytoprotective effects of the bioactive constituents of Pueraria thomsonii in 6- hydroxydopamine (6-OHDA)-treated nerve growth factor(NGF)-differentiated PC12 cells, Phytochemistry, 2010
45. Xiu-Min Li, Hai-Bin Ma, Zhan-Qiang Ma, Lu-Fan Li, Chang-Liang Xu, Rong Qu, Shi-Ping Ma, Ameliorative and neuroprotective effect in MPTP model of Parkinson's disease by Zhen-Wu-Tang (ZWT), a traditional Chinese medicine, Journal of Ethnopharmacology 130, 2010, 19-27.
46. Rui Rui Jia, Yu Lin Gou, Lok Sze Ho, Chuen-Pei Ng, Ning Hua Tan, Hsiao Chang Chan, Anti-apoptotic activity of Bak Foong Pills and its ingredients on 6- hydroxydopamine-induced neurotoxicity in PC12 cells, Cell Biology International 29, 2005, 835-842.
47. Yun-fei Qian, Hua Wang, Wen-bing Yao, Xiang-dong Gao, Aqueous extract of the Chinese medicine, Danggui-Shaoyao-San, inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade, Cell Biology International 32, 2008, 304-311.
48. Andrade, C., The Herbal Treatment of Parkinson's Disease: A Possible Role for BR-16A (Mentat), Ind. J. Psychol. Med., 19, 1996, 2, 82.